Rolley will succeed David Berkal who has been promoted to Chair of the Board for the company.
| ATLANTA, July 18, 2018 /PRNewswire/ -- Medicat, LLC announces the appointment of Daryl Rolley as its new CEO. Rolley will succeed David Berkal who has been promoted to Chair of the Board for the company. https://medicat.com/about-medicat/medicat-leadership/. Rolley is a senior software executive who has worked in multiple software verticals in several countries for the past 18 years, including EVP of Global Sales at Ventyx, Head of Worldwide Sales for Ariba, and SVP and GM for Asia Pacific for FreeMarkets, Inc. Rolley was an executive at McKinsey & Company earlier in his career and most recently was the Chief Commercial Officer at PRGX in Atlanta. “I am delighted to be joining Medicat,” said Rolley. “The company has built a great brand name in the University Health space over many years. I look forward to continuing the company’s longstanding focus of delivering reliable, quality software solutions with outstanding customer support.” “I’m incredibly excited to have Daryl join the Medicat team. His deep experience helping lead and grow software companies will benefit all of our clients as we continue to invest heavily in our support and technology,” said Berkal. ABOUT MEDICAT:
View original content:http://www.prnewswire.com/news-releases/medicat-llc-names-daryl-rolley-new-ceo-300682633.html SOURCE Medicat, LLC |
